Andrew Baum, a former Citi analyst, has left his role as Pfizer's executive vice president and chief strategy and innovation ...

Pfizer is making more changes to its layout in California by stepping away from a South San Francisco office site that used ...

Pfizer has filed a lawsuit against Metsera, Metsera’s board of directors and Novo Nordisk, claiming they breached a merger agreement. The lawsuit, filed in the U.S. District Court for the District of ...

One of the world’s largest biotech companies is closing its only office in the Bay Area. Pfizer is shutting down its office ...

(Reuters) - Pfizer filed an antitrust lawsuit on Monday accusing Danish drugmaker Novo Nordisk of structuring its $9 billion bid for biotech Metsera to stall, not close, the deal, a tactic it said is ...

Pfizer Rewarded Legal Chief for Transaction Wins With 33% Pop in Pay Douglas Lankler "executed key business development transactions to strengthen Pfizer's obesity and cancer drug pipeline," the ...

Pfizer's CEO defended the safety and efficacy of its COVID vaccine and suggested President Trump deserves the Nobel Peace Prize for his role in its development. Why it matters: Trump on Monday ...

Pharmaceutical giant Pfizer has abandoned negotiations to have a breakthrough cancer drug listed on the Pharmaceutical ...

Pfizer (NYSE:PFE) has agreed to acquire Metsera (NASDAQ:MTSR) in a deal worth $47.50 per share in cash, valuing the company at $4.9 billion upfront, with the potential for shareholders to receive up ...

Pfizer's COVID Vaccine for Kids Under 5 , Moves Closer to FDA Approval . Pfizer announced on June 1 that its application to the Food and Drug Administration (FDA) for the vaccine was complete. Pfizer ...

In a major but expected change, pharmaceutical manufacturing giant Pfizer has announced that it will expand the ability of outside researchers and patients enrolled in its clinical trials to access ...

A Pfizer drug designed to address a severe problem associated with sickle cell disease failed to beat a placebo in a Phase 3 clinical trial. It’s the latest setback for Pfizer in this inherited blood ...